Company Aurobindo Pharma Romania Srl with Fiscal Code 27481011
recorded a turnover of 2024 of
500.009,
with a net profit of
227.432
and having an average number of employees of
1.
The company operates in the field of Comerţ cu ridicata al produselor farmaceutice și medicale having the NACE code 4646.
Sales - Ron
Sales, Profit, Employees, Total Income, Financial Results -
Aurobindo Pharma Romania Srl
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Sales - EUR
2.172.720
2.748.661
4.635.483
4.178.531
4.761.295
4.970.888
6.840.910
1.409.641
791.378
500.009
Total Income - EUR
2.245.491
2.925.226
4.742.481
4.288.143
4.898.055
5.013.235
6.884.273
1.683.050
842.603
516.975
Total Expenses - EUR
2.362.578
3.761.356
5.351.411
4.860.316
6.064.660
5.432.007
6.523.947
2.437.459
4.196.040
289.543
Gross Profit/Loss - EUR
-117.086
-836.130
-608.930
-572.173
-1.166.606
-418.772
360.326
-754.409
-3.353.437
227.432
Net Profit/Loss - EUR
-117.086
-836.130
-613.816
-572.173
-1.166.606
-418.772
360.326
-754.409
-3.353.437
227.432
Employees
18
25
26
25
25
25
25
5
2
1
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded.
In the last year of activity, the sales decreased by -36.5%, from 791.378 euro in the year 2023, to 500.009 euro in 2024.
The Net Profit increased by 227.432 euro, from 0 euro in 2023, to 227.432 in the last year.
Check the financial reports for the company - Aurobindo Pharma Romania Srl
Financial Rating - AUROBINDO PHARMA ROMANIA SRL
See the company's note based on the submitted financial data, relative to the industry of which it is a part.
Financial Rating
Payment Limits - Aurobindo Pharma Romania Srl
See the company's payment capacity for situations in which you conclude contracts with payment terms.
Check Payment Limits
Prob. of insolvency - Aurobindo Pharma Romania Srl
It determines the risk of insolvency based on the submitted accounting balance.
Insolvency Probability
Financial Reports - Aurobindo Pharma Romania Srl
Check all the financial reports of the company and know the risks in collaboration with it.
Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
Debts, Equity, Inventories, Receivables, Accounts, Assets -
Aurobindo Pharma Romania Srl - CUI 27481011
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Fixed Assets
457.319
467.626
430.952
452.040
479.395
476.500
541.441
248.418
0
0
Current Assets
3.156.057
4.407.834
6.817.692
6.272.414
6.303.330
7.231.996
10.421.179
5.310.536
1.551.808
558.947
Inventories
379.771
864.937
1.765.254
1.118.102
1.001.588
2.093.262
2.078.279
1.084.458
0
0
Receivables
2.493.704
3.418.605
4.347.418
4.601.108
4.875.331
4.397.511
7.575.535
3.509.021
1.210.132
177.787
Cash
282.582
124.292
705.020
553.204
426.411
741.223
767.364
717.057
341.676
381.160
Shareholders Funds
573.103
2.219.548
1.568.174
967.222
-218.115
-632.752
-258.395
3.480.738
116.745
343.525
Social Capital
2.063.442
4.530.819
4.454.149
4.372.408
4.287.731
4.206.446
4.113.164
8.620.268
8.594.127
8.546.097
Debts
3.060.107
2.666.148
5.685.204
5.772.530
7.057.604
8.391.887
11.231.656
2.092.989
1.444.097
224.425
Income in Advance
0
0
0
0
0
0
0
0
0
0
Exchange rate - RON
4.9743
4.9465
4.9315
4.9468
4.8371
4.7454
4.6535
4.5681
4.4908
4.445
Main CAEN
"4646 - 4646"
CAEN Financial Year
4646
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
558.947 euro in 2024 which includes Inventories of
0 euro, Receivables of
177.787 euro and cash availability of
381.160 euro.
The company's Equity was valued at
343.525 euro, while total Liabilities amounted to
224.425 euro.
Equity increased by 227.432 euro, from 116.745 euro in 2023, to 343.525 in 2024.
Similar services useful for checking companies and business development.
SellNet
Get the contact details for any company and get in touch with it.
Sectoral Studies
Knows the market and develops its own development strategies according to sectorial data.
Databases
Export in excel files the data of the companies selected according to the desired criteria.
Import - Export
Find importers and exporters according to the type of activity and the countries in which they carry it out.
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - Aurobindo Pharma Romania Srl